Ten patients in the dapagliflozin group and one in the glipizide group showed a decrease in TBW of $3% at the time they were discontinued due to this AE. In three patients, an AE of “calculated creatinine renal clearance decreased” was
assessed as severe. The two patients in the dapagliflozin group who discontinued due to an AE of “calculated
creatinine renal clearance decreased” assessed as severe both showed a decrease in bodyweight of$5%.